Stock Talk: TeleHealth in a COVID-19 world and beyond
Link copied to
Stock Talk is a new Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this first edition, host Dr Nigel Finch examines the coronavirus-induced boom of the telehealth industry.
Populating the experts panel this week is David Groberman, CEO and co-founder of HeraMED (ASX:HMD), Marjan Mikel, CEO and managing director of Respiri (ASX:RSH) and Jason Waller, CEO and managing director of InteliCare.
The panel discuss a wide rage of subjects including the advantages of telehealth, how the impact of COVID-19 and government regulation is driving adoption across the sector and the barriers and bottlenecks the industry faces.
So tune in above to hear the panel answer these questions and more.